MATRISTEM MICROMATRIX MM0100

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer,health professional report with the FDA on 2016-05-18 for MATRISTEM MICROMATRIX MM0100 manufactured by Acell, Inc.

Event Text Entries

[45406257] A comprehensive investigation was conducted on discovery. Treating physician was contacted and confirmed the complainant underwent a hair restoration procedure wherein a suspension of prp and micromatrix was injected in the scalp. Physician stated the patient did not come in for any follow-up visits, but patient did call regarding forehead swelling and was instructed to put ice on the area and was advised that the swelling would subside in a few days. Physician stated he has extensive experience with micromatrix? In his personal practice, and he is very comfortable with the product and its safety profile for the particular application that he employs. He stated "i don't believe acell or my procedure was involved" in a potential adverse outcome. Additionally, the physician was concerned about the anesthetic possibly leading to an allergic response, particularly lidocaine. A review of the manufacturing records for the lot identified no substantial deviation and demonstrated the product was manufactured and distributed in compliance with fda, state, local, and manufacturer operating procedures. There was no report of device failure from the attending physician at any time. This mdr has been filed out of an abundance of caution.
Patient Sequence No: 1, Text Type: N, H10


[45406258] Acell received a complaint from a patient who underwent administration of micromatrix? To the scalp via injection. The treating physician opted to treat this particular patient with lidocaine and marcaine prior to injecting the patient with a suspension of micromatrix? And platelet rich plasma (prp). Two days post procedure, the complainant alleged he developed swelling on his forehead, eyelids, nose and nose bridge. He stated he later became nauseous, had post nasal drip, swollen muscles, joint pain, swollen lymph nodes, easy bruising, altered smell, insomnia, anxiety, and tachycardia. Patient claimed he had subsequently been seen by a rheumatologist, ent, allergist, and has presented to an er where he was treated for his anxiety and tachycardia with zoloft as treatment.
Patient Sequence No: 1, Text Type: D, B5


[48356208] This is a follow up report with updated information regarding testing conducted on a sister device from the same lot. A sister graft from the same lot was tested for sterility and results of no growth substantiated that the lot was supplied sterile.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005920706-2016-00004
MDR Report Key5663248
Report SourceCONSUMER,HEALTH PROFESSIONAL
Date Received2016-05-18
Date of Report2016-04-18
Date of Event2016-02-26
Date Mfgr Received2016-04-18
Device Manufacturer Date2016-02-11
Date Added to Maude2016-05-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. BARRY BRAINARD
Manufacturer Street6640 ELI WHITNEY DR.
Manufacturer CityCOLUMBIA MD 21046
Manufacturer CountryUS
Manufacturer Postal21046
Manufacturer Phone8034870493
Manufacturer G1ACELL, INC
Manufacturer Street6640 ELI WHITNEY DR.
Manufacturer CityCOLUMBIA MD 21046
Manufacturer CountryUS
Manufacturer Postal Code21046
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMATRISTEM MICROMATRIX
Generic NameDRESSING, WOUND, COLLAGEN
Product CodeKGN
Date Received2016-05-18
Model NumberMM0100
Lot NumberLP5643-11
Device Expiration Date2018-02-28
OperatorPHYSICIAN
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerACELL, INC
Manufacturer Address6640 ELI WHITNEY DR. COLUMBIA MD 21046 US 21046


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2016-05-18

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.